Document Detail

Different effects of oral conjugated estrogen and transdermal estradiol on arterial stiffness and vascular inflammatory markers in postmenopausal women.
MedLine Citation:
PMID:  16469323     Owner:  NLM     Status:  MEDLINE    
AIMS: We compared the effects of oral conjugated equine estrogen (CEE) therapy and transdermal estradiol therapy on pulse wave velocity (PWV) and circulating levels of vascular inflammatory markers in postmenopausal women and we also explored the interrelationship between the change in PWV and the changes in vascular inflammatory markers. METHODS AND RESULTS: In a randomized 12-month trial, 28 postmenopausal women received a continuous oral CEE plus cyclic medroxyprogesterone acetate (MPA), 28 received a continuous transdermal estradiol patch plus cyclic MPA, and 27 did not receive either therapy. In each subject, we measured the brachial-ankle PWV (baPWV) using an automated device, the blood pressure, and the circulating levels of vascular inflammatory markers (C-reactive protein [CRP], cell adhesion molecules [CAMs], monocyte chemoattractant protein-1 [MCP-1], and matrix metalloproteinase [MMP-9]) before and 12 months after the start of the study. Oral CEE therapy did not change the baPWV but significantly increased the CRP and MMP-9 levels (P<0.05, each) and significantly decreased the CAMs and MCP-1 levels (P<0.05, each). Transdermal estradiol therapy significantly decreased the baPWV, and the CAMs and MCP-1 levels (P<0.05, each) but had no effect on the CRP or MMP-9 levels. No significant changes were seen in the control group. The blood pressures of the subjects remained unchanged. In the transdermal estradiol group, the change in baPWV was not significantly correlated with the changes in vascular inflammatory markers. CONCLUSION: Transdermal estradiol, but not oral CEE therapy, may have antiatherosclerotic effects by improving arterial stiffness. The reduction in baPWV may contribute to the direct effect of estrogen, but not to the decrease in estrogen-induced vascular inflammatory markers.
Hiroyuki Sumino; Shuichi Ichikawa; Shu Kasama; Takashi Takahashi; Hisao Kumakura; Yoshiaki Takayama; Tsugiyasu Kanda; Masahiko Kurabayashi
Related Documents :
9698803 - Calciuria and preeclampsia.
18320533 - Comparison of visual function and ocular hemodynamics between pre- and post-menopausal ...
3181373 - Action and interaction of two alpha 1-adrenoceptor agonists, methoxamine and st 587, on...
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't     Date:  2006-02-15
Journal Detail:
Title:  Atherosclerosis     Volume:  189     ISSN:  0021-9150     ISO Abbreviation:  Atherosclerosis     Publication Date:  2006 Dec 
Date Detail:
Created Date:  2006-10-30     Completed Date:  2007-01-30     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0242543     Medline TA:  Atherosclerosis     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  436-42     Citation Subset:  IM    
Department of Medicine and Biological Science, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi 371-8511, Gunma, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Cutaneous
Administration, Oral
Atherosclerosis / blood,  physiopathology,  prevention & control*
Blood Pressure / drug effects
Estradiol / administration & dosage*,  therapeutic use
Estrogens / administration & dosage*,  therapeutic use
Estrogens, Conjugated (USP) / administration & dosage*,  therapeutic use
Follow-Up Studies
Inflammation / blood*,  physiopathology,  prevention & control
Middle Aged
Treatment Outcome
Vascular Resistance / drug effects*
Reg. No./Substance:
0/Estrogens; 0/Estrogens, Conjugated (USP); 50-28-2/Estradiol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Mild folate deficiency induces a proatherosclerotic phenotype in endothelial cells.
Next Document:  Separation and on-line concentration of saponins from Panax notoginseng by micellar electrokinetic c...